Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
38.76
-0.82 (-2.07%)
Feb 11, 2026, 4:00 PM EST
SHE:301509 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 415.35 | 191.18 | 486.9 | 231.01 | 213.39 | 268.71 |
Trading Asset Securities | 169.98 | 224.25 | 70.62 | 104.75 | - | - |
Cash & Short-Term Investments | 585.33 | 415.43 | 557.52 | 335.76 | 213.39 | 268.71 |
Cash Growth | -16.57% | -25.49% | 66.05% | 57.34% | -20.59% | 232.84% |
Accounts Receivable | 148.5 | 112.89 | 148.92 | 100.65 | 109.16 | 78.78 |
Other Receivables | 0.41 | 0.4 | 16.03 | 64.24 | 13.72 | 42.04 |
Receivables | 148.91 | 113.28 | 164.95 | 164.89 | 122.88 | 120.82 |
Inventory | 147.48 | 194.97 | 216.88 | 231.92 | 178.17 | 131.96 |
Other Current Assets | 792.66 | 780.2 | 917.96 | 19.67 | 15.52 | 7.86 |
Total Current Assets | 1,674 | 1,504 | 1,857 | 752.25 | 529.96 | 529.35 |
Property, Plant & Equipment | 340.77 | 363.05 | 391.89 | 388.05 | 306.15 | 228.53 |
Other Intangible Assets | 45.82 | 47.13 | 48.55 | 49.82 | 48.85 | 9.58 |
Long-Term Deferred Tax Assets | 17.85 | 18.68 | 8.8 | 9.2 | 5.35 | 5.38 |
Long-Term Deferred Charges | 0.17 | 0.19 | 0.31 | 0.45 | 0.57 | 0.46 |
Other Long-Term Assets | 246.71 | 330.46 | 3.77 | 10.23 | 6.63 | 4.56 |
Total Assets | 2,326 | 2,263 | 2,311 | 1,210 | 897.51 | 777.87 |
Accounts Payable | 48.66 | 38.83 | 45.02 | 82.26 | 54.98 | 33.57 |
Accrued Expenses | 11.74 | 21.64 | 24.06 | 32.31 | 22.33 | 27.27 |
Short-Term Debt | - | - | 5 | 24 | 30 | 48.65 |
Current Portion of Long-Term Debt | - | - | - | 11.14 | 3.84 | 5.33 |
Current Portion of Leases | 1.09 | 1.8 | 1.94 | 1.7 | 1.84 | - |
Current Income Taxes Payable | 2.9 | - | 4.9 | 4.81 | 5.96 | 5.07 |
Current Unearned Revenue | 7.46 | 8.8 | 11.24 | 14.3 | 9.38 | 7.09 |
Other Current Liabilities | 29.81 | 21.51 | 28.7 | 93.53 | 16.61 | 103.69 |
Total Current Liabilities | 101.66 | 92.57 | 120.87 | 264.06 | 144.94 | 230.67 |
Long-Term Debt | - | - | - | 46.79 | 38.67 | 22.55 |
Long-Term Leases | 2.01 | 2.96 | 4.71 | 4.43 | 1.12 | - |
Long-Term Unearned Revenue | 7.74 | 9.01 | 6.8 | 7.88 | 3.77 | 4.39 |
Long-Term Deferred Tax Liabilities | 10.05 | 10.03 | 7.26 | 8.02 | 5.13 | 3.55 |
Other Long-Term Liabilities | - | - | - | 0.03 | 0.07 | 0.22 |
Total Liabilities | 121.45 | 114.57 | 139.63 | 331.21 | 193.71 | 261.38 |
Common Stock | 120.45 | 120.45 | 86.03 | 64.53 | 64.53 | 59.28 |
Additional Paid-In Capital | 1,598 | 1,595 | 1,623 | 528.68 | 523.1 | 423.69 |
Retained Earnings | 472.26 | 417.01 | 447.23 | 273.65 | 112.2 | 27.65 |
Comprehensive Income & Other | 13.18 | 16.64 | 14.47 | 11.94 | 3.98 | 5.87 |
Shareholders' Equity | 2,204 | 2,149 | 2,171 | 878.79 | 703.8 | 516.49 |
Total Liabilities & Equity | 2,326 | 2,263 | 2,311 | 1,210 | 897.51 | 777.87 |
Total Debt | 3.1 | 4.76 | 11.64 | 88.07 | 75.46 | 76.53 |
Net Cash (Debt) | 582.23 | 410.67 | 545.88 | 247.69 | 137.93 | 192.18 |
Net Cash Growth | -16.43% | -24.77% | 120.39% | 79.58% | -28.23% | - |
Net Cash Per Share | 4.79 | 3.40 | 5.44 | 2.74 | 1.54 | 2.75 |
Filing Date Shares Outstanding | 120.45 | 120.45 | 120.45 | 90.34 | 90.34 | 90.34 |
Total Common Shares Outstanding | 120.45 | 120.45 | 120.45 | 90.34 | 90.34 | 90.34 |
Working Capital | 1,573 | 1,411 | 1,736 | 488.19 | 385.02 | 298.68 |
Book Value Per Share | 18.30 | 17.84 | 18.02 | 9.73 | 7.79 | 5.72 |
Tangible Book Value | 2,158 | 2,102 | 2,122 | 828.97 | 654.95 | 506.91 |
Tangible Book Value Per Share | 17.92 | 17.45 | 17.62 | 9.18 | 7.25 | 5.61 |
Land | - | 1.37 | 1.35 | 1.33 | 1.21 | 1.24 |
Buildings | - | 126.92 | 110.78 | 106.25 | 74.34 | 67.88 |
Machinery | - | 526.85 | 518.12 | 485.98 | 337.86 | 257.75 |
Construction In Progress | - | 76.82 | 70.61 | 41.44 | 94.84 | 67.65 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.